Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New app and therapy aim to keep pregnant women on opioid treatment

NCT ID NCT06496230

First seen Apr 14, 2026 · Last updated Jun 18, 2026 · Updated 11 times

Summary

This early-stage study tested whether a brief therapy program plus a mobile app could help pregnant and postpartum women stay on their buprenorphine medication for opioid use disorder. Fifteen pregnant women took part, attending therapy sessions and using the app for up to 9 months. The goal was to see if the approach was practical and liked by participants, not to prove it works yet.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Medical University of South Carolina

    Charleston, South Carolina, 29403, United States

Conditions

The condition(s) this trial relates to.

anxiety disorder opiate dependence pregnancy disorder Psychological Well-Being sleep-wake disorder substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.